amotosalen has been researched along with Hemorrhagic Fever, Ebola in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eickmann, M; Fehling, SK; Geisen, C; Kann, G; Krähling, V; MacLennan, S; Rummler, S; Schäfer, R; Schmidt, M; Schüttfort, G; Seidl, C; Seifried, E; Strecker, T; van Kraaij, M; Weinigel, C; Wolf, T | 1 |
1 other study(ies) available for amotosalen and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies.
Topics: Adult; Antibodies, Neutralizing; Blood Donors; Convalescence; Ebolavirus; Furocoumarins; Germany; Hemorrhagic Fever, Ebola; Humans; Immunoglobulin G; Male; Middle Aged; Photosensitizing Agents; Quality Control; Ultraviolet Rays; Virus Inactivation | 2016 |